After a heart attack, foreign-born people are less likely to attend a relapse-preventing Heart School than native-born patients.
Atossa Therapeutics progresses Phase II preventative breast cancer therapy – Pharmaceutical Technology
Share this article Atossa Therapeutics’ CEO discussed updates for its breast cancer program. Credit: NDAB Creativity via Shutterstock Atossa Therapeutics estimates a Q3 readout of